What did @hervirginhair actually say?
The creator says she started semaglutide as a prediabetic whose insurance wouldn't cover Ozempic, found a clinic in Rockville, Maryland charging $750 for six weeks, and is already down 15 pounds three weeks into her 0.25 mg starter dose. She's offering to send followers the clinic link in comments and mentions the clinic also carries "Wagovia."
That's a lot packed into a short clip. She's not just sharing a personal journey, she's actively routing hundreds of thousands of viewers toward a specific third-party clinic. That changes the stakes of the fact-check considerably.
A few things stand out immediately: she mispronounces the drug name multiple times, conflates Ozempic (approved for type 2 diabetes) with Wegovy (approved for weight management), and the $750 price point for six weeks almost certainly means compounded semaglutide, not brand-name Ozempic, regardless of what she or the clinic calls it.
Does the science back this up?
The weight loss timeline she describes is plausible, though on the high end. Fifteen pounds in three weeks at 249 lbs starting weight is aggressive but not impossible, especially in the first weeks when water weight and dietary changes overlap with any early drug effect.
The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed participants lost an average of 14.9% of body weight over 68 weeks with 2.4 mg semaglutide weekly, but the loss is not linear. Early weeks often produce faster drops. At 0.25 mg, the dose she's on is a titration dose, not a therapeutic dose. The FDA-approved escalation schedule exists specifically because higher doses cause more nausea and GI side effects. Three weeks in at the lowest dose producing 15 pounds of loss is biologically possible but includes factors well beyond the drug itself.
For prediabetes specifically, semaglutide has shown real benefit. The STEP 5 trial (Garvey et al., 2022, Nature Medicine) found that semaglutide reduced progression from prediabetes to type 2 diabetes. So her clinical rationale for using it is legitimate.
What did they get wrong (or right)?
She got the core clinical picture roughly right: prediabetes is a genuine indication that many clinicians support, and insurance often does deny Ozempic for weight loss without a type 2 diabetes diagnosis, which is a real and frustrating gap in coverage.
Where she goes wrong is material. First, what she almost certainly purchased is compounded semaglutide, not Ozempic. No legitimate pharmacy sells brand-name Ozempic for $750 per six weeks. The FDA has repeatedly warned that compounded semaglutide products are not equivalent to FDA-approved Ozempic or Wegovy, and quality control varies significantly between compounding pharmacies. The FDA issued a warning in October 2023 specifically about compounded semaglutide products containing unapproved salt forms. Calling it "cheap Ozempic" when it is likely a compounded version is not accurate, and it matters clinically.
Second, offering to send a clinic link to hundreds of thousands of followers with no medical context, no screening, and no discussion of contraindications is genuinely reckless. GLP-1 agonists are contraindicated in people with personal or family history of medullary thyroid carcinoma, and they carry real GI risks that warrant clinical oversight.
What should you actually know?
If your insurance won't cover semaglutide, you have legitimate options, but "someone sent me a link in TikTok comments" should not be the entry point. Telehealth platforms that operate under state medical board oversight, require prescriber review, and are transparent about whether they dispense compounded or brand-name product are a safer path than a clinic recommended in a video caption.
Compounded semaglutide is not automatically dangerous, but it is not the same as Ozempic or Wegovy. The FDA placed compounded semaglutide on its shortage exemption list, but that exemption has been contested and updated repeatedly through 2024. Any clinic selling "cheap Ozempic" should be able to clearly state whether they are dispensing FDA-approved semaglutide or a compounded version, which pharmacy compounds it, and whether a licensed prescriber is reviewing your medical history before dispensing.
- Ask any clinic: Is this FDA-approved semaglutide or a compounded version?
- Confirm a licensed prescriber will review your labs and history before your prescription is written.
- Fifteen pounds in three weeks likely includes water weight and dietary changes, not just drug effect at 0.25 mg.
- Prediabetes is a clinically supported reason to discuss GLP-1 therapy with a provider, but insurance coverage rules are complex and vary by plan.